G. Hatemi Et Al. , "Efficacy of Apremilast for Oral Ulcers Associated with Active Behcet's Syndrome over 28 Weeks: Results from a Phase III Study," ARTHRITIS & RHEUMATOLOGY , vol.70, 2018
Hatemi, G. Et Al. 2018. Efficacy of Apremilast for Oral Ulcers Associated with Active Behcet's Syndrome over 28 Weeks: Results from a Phase III Study. ARTHRITIS & RHEUMATOLOGY , vol.70 .
Hatemi, G., Mahr, A., Ishigatsubo, Y., Song, Y. W., Melikoglu, M., Cheng, S., ... McCue, S.(2018). Efficacy of Apremilast for Oral Ulcers Associated with Active Behcet's Syndrome over 28 Weeks: Results from a Phase III Study. ARTHRITIS & RHEUMATOLOGY , vol.70.
Hatemi, Gülen Et Al. "Efficacy of Apremilast for Oral Ulcers Associated with Active Behcet's Syndrome over 28 Weeks: Results from a Phase III Study," ARTHRITIS & RHEUMATOLOGY , vol.70, 2018
Hatemi, Gülen Et Al. "Efficacy of Apremilast for Oral Ulcers Associated with Active Behcet's Syndrome over 28 Weeks: Results from a Phase III Study." ARTHRITIS & RHEUMATOLOGY , vol.70, 2018
Hatemi, G. Et Al. (2018) . "Efficacy of Apremilast for Oral Ulcers Associated with Active Behcet's Syndrome over 28 Weeks: Results from a Phase III Study." ARTHRITIS & RHEUMATOLOGY , vol.70.
@article{article, author={Gülen HATEMİ Et Al. }, title={Efficacy of Apremilast for Oral Ulcers Associated with Active Behcet's Syndrome over 28 Weeks: Results from a Phase III Study}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2018}